Eyenovia and Senju Pharmaceutical Co. have announced a collaboration agreement to develop Senju’s SJP-0035 for use with Eyenovia’s Optejet dispensing technology as a combination product to treat chronic dry eye disease.
According to an Eyenovia press release, the companies will present a clinical development proposal to the FDA later this year. If successful, the proposal could support a new drug application for the drug-dispensing device for chronic dry eye.
“We believe this product, if approved, has the potential to be used together with other therapies to better address the